Jiangxi Sanxin Medtec Co.,Ltd. (SHE:300453)

Jiangxi Sanxin Medtec Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,526	1,497	1,296	1,334	1,164	938.21
Other Revenue	3.85	3.85	3.66	2.38	-	2.17
Revenue	1,530	1,500	1,300	1,336	1,164	940.39
Revenue Growth (YoY)	12.63%	15.41%	-2.69%	14.75%	23.81%	30.31%
Cost of Revenue	991.88	972.05	847.27	886.52	763.96	636.23
Gross Profit	537.98	528.39	452.79	449.49	400.33	304.15
Selling, General & Admin	192.4	192.01	169.71	193.43	158.38	129.66
Research & Development	68.1	63.98	51.07	40.85	42.15	29.49
Other Operating Expenses	6.12	5.15	10.28	10.24	11.12	8.74
Operating Expenses	269.72	265.17	231.9	245.57	213.34	167.21
Operating Income	268.26	263.21	220.89	203.91	186.98	136.94
Interest Expense	-2.71	-3.11	-4.52	-2.95	-2.08	-1.45
Interest & Investment Income	11.64	12.44	16.01	5.71	2.13	2.06
Currency Exchange Gain (Loss)	2.92	2.92	0.76	1.57	1.78	0.82
Other Non Operating Income (Expenses)	-0.21	-0.23	-1.15	-1.09	-4.62	0.03
EBT Excluding Unusual Items	279.9	275.24	231.98	207.16	184.19	138.4
Gain (Loss) on Sale of Investments	-12.55	-11.02	1.3	1.17	-0.46	0.09
Gain (Loss) on Sale of Assets	-0.14	0.19	0.16	0.01	-0.89	0.01
Asset Writedown	-1.59	-1.1	-0.38	-6.71	-3.22	-4.12
Other Unusual Items	12	12.75	19.71	23.99	15.76	19.27
Pretax Income	277.61	276.06	252.77	225.61	195.37	153.66
Income Tax Expense	28.2	28.36	29.54	26.52	23.56	24.67
Earnings From Continuing Operations	249.41	247.7	223.23	199.1	171.81	128.99
Minority Interest in Earnings	-21.9	-20.3	-16.6	-14.46	-15.9	-13.36
Net Income	227.51	227.4	206.63	184.63	155.91	115.62
Net Income to Common	227.51	227.4	206.63	184.63	155.91	115.62
Net Income Growth	5.59%	10.05%	11.92%	18.42%	34.84%	87.45%
Shares Outstanding (Basic)	516	515	518	515	507	503
Shares Outstanding (Diluted)	517	516	519	515	513	516
Shares Change (YoY)	-0.53%	-0.53%	0.71%	0.35%	-0.53%	-1.38%
EPS (Basic)	0.44	0.44	0.40	0.36	0.31	0.23
EPS (Diluted)	0.44	0.44	0.40	0.36	0.30	0.22
EPS Growth	6.15%	10.64%	11.13%	18.00%	35.56%	90.08%
Free Cash Flow	186.37	172.05	52.34	191.62	154.91	174.76
Free Cash Flow Per Share	0.36	0.33	0.10	0.37	0.30	0.34
Dividend Per Share	0.300	0.300	0.115	0.115	0.115	0.102
Dividend Growth	159.97%	159.97%	-	-	12.58%	99.80%
Gross Margin	35.16%	35.22%	34.83%	33.64%	34.38%	32.34%
Operating Margin	17.54%	17.54%	16.99%	15.26%	16.06%	14.56%
Profit Margin	14.87%	15.16%	15.89%	13.82%	13.39%	12.29%
Free Cash Flow Margin	12.18%	11.47%	4.03%	14.34%	13.31%	18.58%
EBITDA	361.46	352.32	293.65	267.06	242.54	186.78
EBITDA Margin	23.63%	23.48%	22.59%	19.99%	20.83%	19.86%
D&A For EBITDA	93.2	89.11	72.76	63.14	55.55	49.84
EBIT	268.26	263.21	220.89	203.91	186.98	136.94
EBIT Margin	17.54%	17.54%	16.99%	15.26%	16.06%	14.56%
Effective Tax Rate	10.16%	10.27%	11.68%	11.75%	12.06%	16.05%
Revenue as Reported	1,530	1,500	1,300	1,336	1,164	940.39
Advertising Expenses	-	7.52	1.97	4.66	8.16	4.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.